Navigation Links
Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
Date:5/29/2012

PORTSMOUTH, N.H., May 29, 2012 /PRNewswire/ -- Novocure™, a commercial stage private oncology company, announced today that data from pre-clinical and clinical studies evaluating NovoTTF™ therapy will be presented and published online as part of the 48th Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL, June 1-5, 2012.    

The data include the trial design of an ongoing Phase III (IDE) clinical trial of tumor-treating fields (TTFields) together with temozolomide compared to temozolomide (TMZ) alone in patients with newly diagnosed glioblastoma, and experimental data testing TTFields treatment in non-small cell lung cancer and pancreatic cancer.

In addition to these updates, NovoTTF™ therapy will be highlighted at an ASCO Educational Session on Monday, June 4 at 11:30 am in room S406 titled "Glioblastoma: Taking the Standard of Care to the Cutting Edge."  The lecture will be presented by Dr. Philip H. Gutin, Chair of the Department of Neurosurgery and Co-Executive Director of the Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.

  • Glioblastoma: Taking the Standard of Care to the Cutting Edge

Presenter:  Dr. Philip H. Gutin, Memorial Sloan Kettering Cancer Center, New York
Date/Time:  Monday, June 4, 11:30 am
Session:  ASCO Educational Session
Location: room S406

A future perspective on NovoTTF therapy will be presented as a part of the ASCO Industry Expert Theater on Sunday, June 3 from 11:30 am-12:30 pm in the ASCO Oncology Professionals Hall.

  • The Fourth Cancer Treatment Modality – Going Beyond Pharmacology with Tumor Treating Fields (TTFields).

Presenters:  Dr. Eilon D. Kirson, Chief Science Officer and Head o
'/>"/>

SOURCE Novocure
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... our ability to target experimental cancer treatments ... hand, and more are on the way ... drugs, MILAN, Italy, April 27 , At today,s ... Meeting,of the European Association for the Study of the Liver ...
... Virology Translate Into New Promising Drugs to Combat Hepatitis ... ... Stem Cells of Potential Benefit in Liver ... Liver Diseases, At today,s sessions of the 43rd Annual Meeting of the European,Association ...
Cached Medicine Technology:Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 2Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 3Basic Science Discoveries Yield Progress in Hepatology 2Basic Science Discoveries Yield Progress in Hepatology 3Basic Science Discoveries Yield Progress in Hepatology 4
(Date:7/11/2014)... WA (PRWEB) July 11, 2014 College ... within one week of injury, but developed recurrent instability ... at the American Orthopaedic Society for Sports Medicine’s ( ... guide team physicians in providing the most optimal treatment ... who suffered an anterior shoulder instability event, and found ...
(Date:7/11/2014)... Re-tearing a repaired knee Anterior Cruciate Ligament (ACL) ... presented today at the American Orthopaedic Society for Sports ... education regarding modifiable risk factors may minimize the chance ... suggests that a few risk factors such as, age, ... to the possibility of re-injury," said lead author, Christopher ...
(Date:7/11/2014)... Bethpage, NY (PRWEB) July 11, 2014 Wild ... Kullen, is proud to announce they are opening a fifth ... , Wild by Nature offers one of the largest selections ... of people diagnosed with celiac disease, these stores have become ... a gluten-free diet. , Gluten sensitivity, and gluten intolerance, is ...
(Date:7/11/2014)... BellasDress, the experienced dressmaker in the ... suppliers when it comes to beach wedding dresses ... of beach wedding outfits in its online shop. Included ... outfits. , BellasDress has been considered as one ... to the company’s senior spokesman, BellasDress provides superb special ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Growing old was thought ... then. However, in recent studies, it was shown that many of ... credence behind them. As it turns out, the elderly can still ... , Of course, with all the time in the world, older ... them to indulge their passions in the twilight of their lives. ...
Breaking Medicine News(10 mins):Health News:Intercollegiate Contact Athletes with Shoulder Instability Return to In-Season Sports, Study Shows 2Health News:Wild by Nature Opens New Location 2Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3
... of a recent study researchers say Lipid-lowering drugs can be ... at a follow-up appointment with a doctor. ,Researchers ... during a hospital stay vs. in an outpatient setting and ... States and Canada were involved in the study, 175 patients ...
... known scientist and accomplished businessman of the U.S. holding ... to set up a high end rapid //diagnostic centre ... be a marketing, selling and research company. ... BioAsia 2004 conference Bangalore on February 28, he said ...
... findings researchers say the risks and benefits of using ... Researchers from Sweden studied more than 3,000 men who ... had their intellectual capacity tested at age 18 years ... for the young men. ,Results of the study ...
... use of hormone replacement therapy among breast cancer survivors has ... rate of recurring or new cancers. ,Swedish researchers embarked ... the disease and therefore subject to the same menopausal symptoms ... 1,300 women over five years. After the initial 345 women ...
... serious consequence of osteoporosis. Such a break can lead to ... ,According to a recent study , it was found ... to be effective in reducing the risk for a vertebral ... the drug can reduce the risk of breaking a bone ...
... reprogram their brains to improve motor skills, say researchers ... ,Functional magnetic resonance imaging and a "cyberglove" record ... redirect motor commands. Stroke or traumatic brain injury results ... until now, scientists were not sure which neurons compensated ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: